MTVA
MetaVia Inc.

14,648
Mkt Cap
$18.5M
Volume
176,038.00
52W High
$2.75
52W Low
$0.5555
PE Ratio
-0.56
MTVA Fundamentals
Price
$0.6912
Prev Close
$0.764
Open
$0.76
50D MA
$0.9638
Beta
0.93
Avg. Volume
83,961.35
EPS (Annual)
-$3.56
P/B
2.92
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
MetaVia Presents Positive New Phase 2a Data on Vanoglipel (DA-1241) in Patients with Presumed MASH at the AASLD The Liver Meeting 2025
MetaVia Presents Positive New Phase 2a Data on Vanoglipel (DA-1241) in Patients with Presumed MASH at the AASLD The Liver Meeting 2025 MetaVia Presents Positive New Phase 2a Data on Vanoglipel...
PR Newswire·13d ago
News Placeholder
More News
News Placeholder
MetaVia Reports Third Quarter 2025 Financial Results and Provides Corporate Update
MetaVia Reports Third Quarter 2025 Financial Results and Provides Corporate Update MetaVia Reports Third Quarter 2025 Financial Results and Provides Corporate Update PR Newswire CAMBRIDGE, Mass...
PR Newswire·14d ago
News Placeholder
MetaVia to Present New Phase 1 and Pre-Clinical Data on DA-1726 at ObesityWeek 2025
MetaVia to Present New Phase 1 and Pre-Clinical Data on DA-1726 at ObesityWeek 2025 MetaVia to Present New Phase 1 and Pre-Clinical Data on DA-1726 at ObesityWeek 2025 PR Newswire CAMBRIDGE, Mass...
PR Newswire·16d ago
News Placeholder
MetaVia Announces Poster Presentation on Vanoglipel (DA-1241) at the AASLD Liver Meeting
MetaVia Announces Poster Presentation on Vanoglipel (DA-1241) at the AASLD Liver Meeting MetaVia Announces Poster Presentation on Vanoglipel (DA-1241) at the AASLD Liver Meeting PR Newswire...
PR Newswire·24d ago
News Placeholder
MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference
MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference PR Newswire CAMBRIDGE, Mass., Oct. 14, 2025...
PR Newswire·1mo ago
News Placeholder
MetaVia to Present at Upcoming Investor and Industry Conferences
MetaVia to Present at Upcoming Investor and Industry Conferences MetaVia to Present at Upcoming Investor and Industry Conferences PR Newswire CAMBRIDGE, Mass., Aug. 26, 2025 CAMBRIDGE, Mass., Aug...
PR Newswire·3mo ago
News Placeholder
MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference
MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference PR Newswire CAMBRIDGE...
PR Newswire·10mo ago
News Placeholder
MetaVia to Participate in the 9th Annual MASH-TAG 2025 Conference After Releasing Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH
MetaVia to Participate in the 9th Annual MASH-TAG 2025 Conference After Releasing Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH MetaVia to...
PR Newswire·11mo ago
News Placeholder
MetaVia Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH
MetaVia Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH MetaVia Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of...
PR Newswire·11mo ago
News Placeholder
MetaVia to Present at the Emerging Growth Conference in December
MetaVia to Present at the Emerging Growth Conference in December MetaVia to Present at the Emerging Growth Conference in December PR Newswire CAMBRIDGE, Mass., Dec. 2, 2024 CAMBRIDGE, Mass., Dec. 2...
PR Newswire·1y ago

Latest MTVA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.